Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial.
Alagaratnam J, Stöhr W, Hamlyn E, Porter K, Toombs J, Heslegrave A, Zetterberg H, Gisslén M, Underwood J, Schechter M, Kaleebu P, Tambussi G, Kinloch S, Miro JM, Kelleher AD, Babiker A, Frater J, Winston A, Fidler S; SPARTAC Trial Investigators.
Alagaratnam J, et al. Among authors: winston a.
J Virus Erad. 2024 Jun 13;10(2):100381. doi: 10.1016/j.jve.2024.100381. eCollection 2024 Jun.
J Virus Erad. 2024.
PMID: 38988673
Free PMC article.